Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay [TheStreet.com]
Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay
Waters (WAT) was upgraded by The Goldman Sachs Group, Inc. to "strong-buy".
Waters (WAT) was upgraded by Evercore Inc from "in-line" to "outperform". They now have a $350.00 price target on the stock.
3 Out-of-Favor Stocks That Concern Us [Yahoo! Finance]